Found 8874 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) PHASE1 Primary trial objective in this single arm trial is to assess the safety an...
Show More Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers PHASE1 This is a pilot, explorative, study to test the feasibility and safety of s...
Show More Location
Unit of Oncology - Ospedali Riuniti of Bergamo
Learn More & Join Trial
Human Upper Extremity Allotransplantation PHASE2 Background: Millions of people each year sustain injuries, have tumors surg...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury PHASE1 Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors PHASE2 Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy PHASE2 The trial is designed as a multi-center, open label Phase 2 trial that inve...
Show More Location
3203; Antwerp University Hospital; Department of Medical Oncology
Learn More & Join Trial
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas PHASE1 This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor PHASE2 The purpose of this study is to determine whether ATIR is safe and effectiv...
Show More Location
Algemeen Ziekenhuis Sint-Jan
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients PHASE1 The study is an open-label Phase 1 single dose-escalation safety study of C...
Show More Location
Mayo Clinic Florida
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer PHASE2 The objective of this study is to assess the efficacy, safety of MRG003 as ...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial